I once let an Adalysis alert sit in my inbox for 11 days. It was right: one responsive search ad was losing on conversion rate at a confidence level I would accept from any statistician. The tool surfaced it within about a day of the data becoming conclusive. Then it waited for me.
I was in client calls, a Shopping feed was broken, and a QA sheet needed filling in for a launch. The analysis was free; acting on it was the expensive part. That gap is the whole Adalysis story.
Adalysis is one of the better-built PPC analysis tools I have used. Its ad-testing math is more honest than most in-house spreadsheets. But it is priced for a world where a human still executes every decision it surfaces. If that describes your team, you can get real value from it. If you expected alerts to turn into changes without you, you bought the wrong product category.
The question everybody types into Google first: Adalysis charges by monthly ad spend, not seats. A third-party pricing listing puts the entry plan at $149 per month for up to $50,000 in monthly spend, with a 14-day free trial that does not require a card and roughly 15% off for annual billing.
Tiers rise with spend, and the tier reassesses each month based on what you actually spent. A slow quarter costs less. That part is sensible.
Say you run $30,000 a month across four accounts. Adalysis costs $149. Now count the rest:
Five hours a week is a fair estimate once an account is stable. It is cheap if it is not. At an $85 loaded hourly cost for a competent PPC manager, that is roughly $1,700 a month of human time attached to a $149 subscription.
The software is about 8% of what this workflow costs. I am not making the case against buying it. I am saying that comparing $149 with an agency retainer is nonsense unless you also price the person working the queue.
The tier model has a second quirk. Price tracks spend, but the work Adalysis saves tracks account count and structural mess. One consolidated $45,000-a-month ecommerce account running mostly Performance Max has few manual levers left. Fourteen local-service accounts at $3,000 each have hundreds: duplicate keywords, conflicting negatives, ad groups with one orphaned RSA, landing pages someone changed in March.
Adalysis is strongest when many messy accounts create more work than one person can reliably inspect. Check whether that is your situation before you fixate on the price.
Everything else Adalysis does, another tool can do in some form. Ad testing is where it earns its reputation.
It runs a test automatically when an ad group has two or more competing ads. It identifies the period when those ads actually served at the same time, so you do not compare a two-week ad with a two-month ad. It reports confidence by metric rather than delivering one grand verdict.
Anything below 90% confidence appears as a dash, not a winner. That is a small design choice I respect more than most feature-page copy. It refuses to tell you a winner exists when it does not. I have watched account managers call a test at 40 conversions and a 12% CTR gap. Adalysis will not let you do that with a straight face.
The feature I would actually pay for is testing across ad groups. Single-ad-group tests die of thin data in most accounts. If an ad group gets 300 clicks a month, you may wait a quarter for significance, and the offer may change before then.
Adalysis lets you group ads by text pattern or label and test that pattern across ad groups. It also builds heatmaps for RSA asset combinations and reports metrics including CTR, conversion rate, and cost per conversion. That changes the question:
Not: “Which of these two ads won in this ad group?”
But: “Does price-led messaging beat outcome-led messaging in this account?”
The second answer survives your next campaign rebuild. Test themes across the account, not isolated ads inside one ad group.
There is one place where the tool stops advising and acts: automatic pausing of losing ads.
You enable it per ad group. You can set the deciding metric, required significance level, minimum test duration, and minimum performance criteria before an ad becomes eligible. Every pause is archived with the test result behind it, so you can reconstruct why an ad died six weeks later.
It is well-built engineering. Almost nobody I have worked with turns it on.
That reluctance explains this product category. When I ask why, nobody says the statistics are wrong. They say pausing an ad in a client account without a human eyeball feels like a liability. So the alert stays in the queue until Thursday.
If you run auto-pause, this is the configuration I would use:
The other half of Adalysis is the audit: standing checks across connected accounts. It produces alerts for negative keyword conflicts, duplicate search terms, quality-score movement, and landing-page problems, plus structural issues such as ad groups with no RSAs, one-ad ad groups, duplicate ads, misspellings, and disapproved assets.
Two have saved me actual money. The misspelling check caught a headline live for nine days with “reponsive” in it. Another alert flags when Google’s auto-apply recommendations are enabled. That matters because account changes can follow, often after somebody on the client side clicks a toggle they should not have touched.
Quality-score tracking is the quieter win. Google shows today’s number and expects you to remember the trend. A keyword sliding from 7 to 4 over two months can look identical to one that has always been a 4.
Adalysis preserves the history. That makes quality score a change log rather than a vanity metric: you can see when the score fell, then look for what shipped that week. Usually, it is a landing-page edit nobody logged. I have written elsewhere about how much of quality-score work is mechanical versus judgment. This is the mechanical part done well.
Reporting is competent rather than exciting: roughly 50 prebuilt templates, white-label options, live data, and exports. If your agency rebuilds the same Looker Studio dashboard for every client, that may justify the subscription on its own.
The audit does not solve problems; it makes the next problem impossible to miss.
Here is the honest boundary. Adalysis syncs with ad accounts once a day, in the early hours. Every conclusion is therefore a snapshot. Every action except pausing a losing ad waits for a person.
The tool compresses diagnosis from hours to minutes and leaves execution where it was. For a team with capacity, that is a good trade. For a team already three weeks behind, buying Adalysis mostly means discovering, in higher resolution, how far behind you are.
I read through public review pools before writing this, partly to check my own bias. Adalysis has 119 verified reviews on GetApp and 92 on Trustpilot. That is thin by software standards, but about right for a tool aimed at people managing other people’s ad accounts.
The complaints cluster tightly:
That last point matches my experience. It can help you edit and bulk-modify RSAs, but it is not a copywriting tool. It does not pretend to be.
In the reviews I read, the praise had a consistent shape: people value reviewing many accounts quickly and catching duplicate keywords or non-converting headlines in minutes rather than hours. That is an agency compliment, phrased in agency units of time saved.
The learning-curve complaint is the useful signal. It is not really about the UI. Adalysis assumes you know what to do with an n-gram breakdown, a significance threshold, and a quality-score history. It hands you good instruments and no opinion about where to steer.
This is not a defect. It is an audience definition: Adalysis is built for people whose job is making PPC decisions.
The question I get most often is some version of: can AI just run my creative tests?
It can, but only if you automate the whole loop. Generating variants is the fun part. It is also the least valuable part. A tool that only generates leaves you with 40 headlines nobody retired.
A working loop has five stages. If one still needs a human, the loop runs at human speed.
Two things break the loop in practice, and neither is AI. First: measurement. If conversion tracking counts form fills that never become customers, you optimize toward junk faster than you could by hand. Fix tracking first.
Second: scope. Ad copy is half a test at most. The promise in the headline is judged against the page behind the click. A price-led headline pointing to a landing page that leads with credentials can lose for reasons that have nothing to do with the copy.
This is the part I care most about at groas. The groas paid search engine writes and tests ad copy while deploying dynamic landing pages in the same workflow. Creative testing that stops at the ad is testing half the funnel.
I would sign the check for three profiles.
Buy Adalysis when insight is your constraint and someone has time to act on it.
The tells are unglamorous and easy to check. Open your Adalysis account and find the oldest unresolved alert. If it is more than two weeks old, you are paying $149 a month for a mirror.
Then check how many flagged items from last month you actually applied. Below half, and the subscription is funding awareness rather than performance. Finally, look at your ad copy. If the live headlines are ones you wrote last quarter and the test queue has been “next sprint” since then, diagnosis was never the constraint.
A better queue does nothing for a team with no capacity to work it. Adding software to a capacity problem is the most expensive mistake in this category.
At that point, the honest answer is to hire someone or hand execution to a machine. I would argue for the machine at any spend under six figures a month.
The verdict is simple. Adalysis is very good software with statistics I trust more than most people’s judgment. It is sold to an operating model that is running out of road: one human, one daily sync, one queue.
Buy it if the human in that sentence has time. Test both sides properly rather than believing either sales page. Adalysis gives you 14 days with no card. groas gives you seven days before you pay anything.
Judge them on one number with nothing to do with features: what changed in the account by the end of the trial, and how much of that change came out of your week. My 11-day alert answered that question before I saw a pricing page.
